Health improvement in Poland is contingent on continued extensive tobacco control measures

• Autorzy: Zatonski W. , Zatonski M. , Przewozniak K.
• Języki publikacji: EN

Abstrakty

EN

Tobacco smoking is a major avoidable single cause of premature mortality in Poland. Almost one in three Polish males do not live to 65 years of age, and almost half of this premature mortality can be traced back to the much higher smoking prevalence in Poland than in Western Europe – every third Polish male and every fourth Polish female smokes daily. However, the current health situation in Poland is much better than two decades ago when the country entered a period of political and economic upheaval. In the early 1990s, the state of health of the Polish population was catastrophic and its tobacco consumption levels the highest in the world. In the early 1990s, the probability of a 15-year-old Polish boy living to the age of 60 was not just twice lower than in Western Europe, but also lower than in China or India. The health policy of limiting the health consequences of smoking conducted by the European Union and, in the last two decades, by the Polish parliament and government, helped to stop this health catastrophe. In Poland, cigarette consumption has decreased by 30% since 1990, as did lung cancer mortality among males. Despite this progress, tobacco smoking remains the most serious health problem in Poland. Therefore, comprehensive tobacco control policy should not only be continued, but expanded and accelerated. The EU Tobacco Products Directive proposes a package of actions for reducing tobacco-related health harm in Europe. The Directive proposal is rational, science-and-evidence based, and grounded on the best practice examples from other countries. Both the Polish tobacco control law and the WHO Framework Convention on Tobacco Control (FCTC), ratified by Poland in 2006, oblige our country to support tobacco control, including all the initiatives taken by the European Union.

Słowa kluczowe

EN

health improvement; Poland; human health; tobacco control; tobacco-caused disease; human disease; European Union; directive; tobacco smoking

• Wydawca: -
• Czasopismo: Annals of Agricultural and Environmental Medicine
• Rocznik: 2013
• Tom: 20
• Numer: 2
• Opis fizyczny: p.405-411,fig.,ref.

Twórcy

autor

Zatonski W.

• Department of Cancer Epidemiology and Prevention, Maria Skłodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland

autor

Zatonski M.

• Health Promotion Foundation, Warsaw, Poland

autor

Przewozniak K.

• Department of Cancer Epidemiology and Prevention, Maria Skłodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland

Bibliografia

• 1. Zatonski W, Manczuk M, Sulkowska U, and HEM project team. Closing the health gap in the European Union. Cancer Center and Instituteof Oncology. Warsaw 2008 (Polish edition: Zatonski W, ManczukM, Sulkowska U, i zespół projektu HEM. Wyrównywanie różnic wzdrowiu między krajami Unii Europejskiej. Centrum Onkologii-Instytut. Warszawa 2011) (available at: www.hem.waw.pl).
• 2. Zatonski W, McMichael AJ, Powles JW. Ecological study of reasons for the sharp decline in mortality from ischaemic heart disease in Polandsince 1991. Br Med J. 1998; 316(7137): 1047–51.
• 3. Zatonski WA, Bhala N. Changing trends of diseases in Eastern Europe: Closing the gap. Public Health 2012; 126: 248–252.
• 4. Zatonski W. Health-happiness of Poland and its citizens. Polish economy: Development of regions. Warsaw 2012: 216–225 [in Polish].
• 5. Zatoński W, Przewoźniak K, Sulkowska U, West R, Wojtyła A. Tobacco smoking in countries of the European Union. Ann Agric Environ Med.2012; 19(2): 181–192.
• 6. Feachem R. Health decline in eastern Europe. Nature 1994; 367(6461): 313–4.
• 7. World Bank: Development in practice. Curbing the epidemic. Governments and the economics of tobacco control. Washington (DC)1999 (Polish edition: Bank Światowy: Rozwój w praktyce. Przeciwkoepidemii. Działania rządów a ekonomika ograniczenia konsumpcjitytoniu. Medycyna Praktyczna, Kraków 2002).
• 8. Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE. Lung cancer death rates in lifelong non-smokers. J Natl Cancer Inst. 2006;98(10): 691–9.
• 9. Wramner B, Zatoński W, Pellmer K. Premature mortality in lung cancer as an indicator of effectiveness of tobacco use prevention in a genderperspective – a comparison between Poland and Sweden. Cent Eur JPubl Health. 2001; 9(2): 69–73.
• 10. Zatoński W. Lung cancer trends in selected European countries: What we can learn from the Swedish experience with oral tobacco (snuff).In: European Status Report 2003 on Oral Tobacco. European Networkfor Smoking Prevention, Brussels 2003: 37–54.
• 11. Stahl T, Wismar M, Ollila ELE, Leppo K. Health in All Policies: Prospects and potentials. Ministry of Social Affairs and Health,Finland, Helsinki 2006.
• 12. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. Br Med J.2004; 328(7455): 1519.
• 13. Zatoński W, Przewoźniak K, Sulkowska U, Mańczuk M, Gumkowski J. Tobacco smoking in male and female population, Poland 1974–2004.Zeszyty Naukowe Ochrony Zdrowia. Zdrowie Publiczne i Zarządzanie2009;7(2):4–11 [in Polish]
• 14. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.Circulation 2004; 109(9): 1101–7.
• 15. Central Statistical Office. Statistical Yearbooks. Warsaw 1928–2010.
• 16. World Health Organization. The Framework Convention on Tobacco Control. Geneva 2003 (available at: (http://www.mz.gov.pl/wwwmz/index?mr=m9&ms=&ml=pl&mi=91&mx=0&ma=18876)
• 17. European Commission. Green Paper. Towards a Europe free from tobacco smoke: policy options at EU levels. COM(2007) 27 final.Directorate-General Health and Consumer Protection, Brussels 2007.
• 18. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet1997; 349: 1498–1504.
• 19. Peto R, Lopez A, Boreham J, Thun M, Heath C Jr. Mortality from Smoking in Developed Countries 1950–2010. Oxford University Press,Oxford (UK) 1994 (updated 2012).
• 20. Forey B, Hamling J, Lee P, Wald N. International Smoking Statistics. A collection of historical data from 30 economically-developed countries(2nd edition). The Wolfson Institute of Preventive Medicine, Oxford 2002.
• 21. Zatoński W. A nation’s recovery. Case study of Poland’s experience in tobacco control. Health Promotion Foundation, Warsaw 2003 [inPolish].
• 22. Sejm of the Republic of Poland. The Law on Health Protection Against Effects of Tobacco Use. Dziennik Ustaw 1996, Nr. 10, poz. 55. [in Polish]
• 23. Blanke DD, de Costa e Silva V. Tools for advancing tobacco control in the 21st century. Tobacco control legislation: An introductory guide.World Health Organization, Geneva 2004.
• 24. Zatoński W. Democracy and Health. Tobacco Control in Poland. In: de Beyer J, Brigden LW (eds): Tobacco Control Policy. Strategies, Successesand Setbacks. The World Bank and the International DevelopmentResearch Center, Washington 2003: 97–120.
• 25. World Health Organization. WHO Framework Convention on Tobacco Control. Guidelines for implementation of the WHO FCTC. Article 5.3.Article 8. Articles 9. and 10. Article 11. Article 12. Article 13. Article
• 14. Geneva 2011 (Polish version available at: http://www.mz.gov.pl/ wwwmz/index?mr=m9&ms=&ml=pl&mi=91&mx=0&ma=19196).
• 26. Ministry of Health. Global Adult Tobacco Survey. Poland 2009– 2010. Warsaw 2010 (Polish version available at: http://www.mz.gov.pl/wwwmz/index?mr=m9&ms=772&ml=pl&mi=772&mx=0&ma=16384).
• 27. Woynarowska B, Mazur J (eds). Changes in health behaviour and selected health indicators of schoolchildren in the years 1990–2010.Institute of Mother and Child, Warsaw 2012.
• 28. Bandosz P, O’Flaherty M, Drygas W, Rutkowski M, Koziarek J, Wyrzykowski B, et al. Decline in mortality from coronary heart disease in Poland after socio-economic transformation: modelling study. Br Med J. 2012; 344: d8136.
• 29. European Commission. Proposal for a Directive of the European Parliament and of the Council on the approximation of the laws,regulations and administrative provisions of the Member Statesconcerning the manufacture, presentation and sale of tobacco andrelated products. COM(2012) 788 final. Brussels, 19 December 2012.
• 30. US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta(GA) 2004.
• 31. International Agency for Research on Cancer. A Review of Human Carcinogens: Personal Habits and Indoor Combustions. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 100E. Lyon 2012.
• 32. German Cancer Research Centre (DKFZ). Additives in Tobacco Products. Contribution of Carob Bean, Cellulose Fibre, GuarGum, Liquorice, Menthol, Prune Juice Concentrate and Vanilin toAttractiveness, Addictiveness and Toxicity of Tobacco Smoking.Heidelberg 2012.
• 33. US Department of Health and Human Services. The Health Consequences of Smoking: Nicotine Addiction. A Report of the SurgeonGeneral. Rockville (MD) 1988.
• 34. European Commission. Tobacco. Eurobarometer 72.3. Directorate General Health and Consumers, Brussels 2010.
• 35. Baska T, Sovinova H, Nemeth A, Przewozniak K, Warren CW, Kavcova E and the Czech Republic, Hungary, Poland and Slovakia GYTS Collaborative Group. Findings from the Global Youth TobaccoSurvey (GYTS) in the Czech Republic, Hungary, Poland and Slovakia– smoking initiation, prevalence of tobacco use and cessation. PrevMed. 2006; 51: 110–116.
• 36. WHO Report on the Global Tobacco Epidemic, 2008. The MPOWER package. World Health Organization, Geneva 2008.